GlassScriptPhysician profile
David W Glenn
NPI 1619381852
$1,192.92
in general payments reported to CMS, 2019-2025
17 companies · $29.55 in 2025
The $29.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.01 · 2022: $426 · 2023: $688 · 2024: $32.24 · 2025: $29.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $243.39 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $219.15 | 2022-2024 | Breztri, Farxiga, Airsupra |
| Boston Scientific Corporation | $147.22 | 2022 | |
| Pfizer INC. | $96.16 | 2022-2023 | |
| Exact Sciences Corporation | $89.16 | 2023-2024 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $63.08 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $60.72 | 2022-2023 | Austedo Xr |
| Abbott Laboratories | $53.12 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $50.04 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.60 | 2022 | |
| Corium, LLC | $25.92 | 2023 | Azstarys |
| Si-Bone, INC. | $23.04 | 2023 | |
| Abbvie INC. | $18.36 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.39 | 2023 | Eliquis |
| Astellas Pharma US INC | $17.20 | 2023 | Veozah |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $14.19 | 2025 | Dexcom G6 Transmitter |
| Grifols USA, LLC | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Glenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.